Treace Medical Concepts TMCI
NASDAQ TMCI
$4.53 -0.10 (-2.16%)
As of: Sep 9, 2026 · 3:59 PM EDT

Treace Medical Concepts (TMCI) Share-based Compensation Growth (3y) (2023 - 2026)

Analysis

Treace Medical Concepts (TMCI) Share-based Compensation Growth (3y) (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. Growth (3y) (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn 8.37%
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn -22.92%
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn 19.64%
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn -28.31%
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn 0.55%
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn 4.11%
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn 7.30%
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn -0.59%
9 Steris 21.90 Bn 21.43 Bn 684.20 Mn 3.40%
10 Treace Medical Concepts 312.82 Mn 267.20 Mn 35.61 Mn 21.58%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 21.58%
Mar 31, 2026 43.97%
Sep 30, 2025 52.19%
Jun 30, 2025 69.60%
Mar 31, 2025 83.41%
Dec 31, 2024 87.73%
Sep 30, 2024 -3.68%
Jun 30, 2024 -7.38%
Mar 31, 2024 164.13%
Dec 31, 2023 159.41%
Sep 30, 2023 246.32%
Jun 30, 2023 143.85%
Mar 31, 2023 134.41%